Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)

Market Cap	8.68B -14.4%
Revenue (ttm)	3.67B -7.6%
Net Income	399.54M +2.4%
EPS	0.40 +1.8%
Shares Out	989.20M
PE Ratio	21.93
Forward PE	18.46
Dividend	0.40 (4.51%)
Ex-Dividend Date	Oct 22, 2025

Volume	7,899,211
Average Volume	12,908,306
Open	8.91
Previous Close	8.77
Day's Range	8.70 - 8.91
52-Week Range	8.58 - 11.79
Beta	0.35
RSI	41.53
Earnings Date	Apr 23, 2026

About SHE:002332

Zhejiang Xianju Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid raw materials and preparations in China and internationally. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progesterone, non-hormone series, newchem API, and intermediates products; and CDMO and CMO services. It also engages in medical equipment production; technical ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 3,205
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002332

Financial Performance

In 2025, SHE:002332's revenue was 3.76 billion, a decrease of -6.04% compared to the previous year's 4.00 billion. Earnings were 449.64 million, an increase of 13.21%.